March 01, 2015 8:16 AM ET


Company Overview of Jounce Therapeutics, Inc.

Executive Profile

Cary G. Pfeffer M.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships


Dr. Cary G. Pfeffer, M.D., served as an Interim Chief Executive Officer of Jounce Therapeutics, Inc., until July 10, 2014. Dr. Pfeffer is a Partner at Third Rock Ventures, LLC. Dr. Pfeffer joined Third Rock Ventures in 2007 and drives its overall interface strategy with pharmaceutical and large biotechnology companies as well as institutions. At the firm, he leads the partner development efforts, including building and maintaining strong relationships to work with large ...

Corporate Headquarters

1030 Massachusetts Avenue
Cambridge, Massachusetts 02138

United States

Phone: 617-585-2000
Fax: 617-859-2891

Board Members Memberships

Director and Member of Nominating & Corporate Governance Committee


Columbia University
The University of Pennsylvania
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Jounce Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at